Conference icon

Conference

24-WEEK RESULTS OF A BLINDED PHASE IIB DOSE-RANGING STUDY OF BARICITINIB, AN ORAL JAK1/JAK2 INHIBITOR, IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
Expand authors...
Volume:
52
Pages:
44-45
Publication date:
2013-04-05
ISSN:
1462-0324
URN:
uuid:4f05f9eb-5934-42f8-920c-3854c00909f0
Source identifiers:
405544
Local pid:
pubs:405544

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP